SYNTHIA (Merck KGaA)NEW

SYNTHIA Retrosynthesis Software is an AI-powered tool for organic chemistry developed by Merck KGaA. The application combines advanced search algorithms with tens of thousands of expert-encoded reaction rules to design optimal synthetic pathways for target molecules. This enables chemists in pharmaceutical research and materials science to produce novel compounds more efficiently in the laboratory.

The platform dissects complex molecular structures retrosynthetically and proposes step-by-step reaction routes originating from commercially available starting materials. Users can customize search parameters, including functional group protection, stereochemical constraints, step limits, and cost parameters. SYNTHIA evaluates millions of potential pathways automatically, highlighting the most viable options.

In addition to pathway generation, SYNTHIA integrates seamlessly with internal building block inventories and corporate chemical databases. This substantially reduces R&D cycle times in drug discovery and minimizes trial-and-error in wet lab execution. The software is continuously updated by a dedicated team of computational and organic chemists.

• Advanced Retrosynthesis Engine — Combines AI algorithms with expert-encoded chemical reaction rules to automatically generate valid synthetic pathways. Accurately handles complex stereochemistry and protecting group chemistry.
• Customizable Filtering & Evaluation — Allows users to filter and rank routes by step count, cost, yield, and starting material availability. Proprietary building block databases can be incorporated.
• Interactive Pathway Visualization — Provides an intuitive interface for exploring, editing, and comparing alternative reaction trees in real time.

SYNTHIA is designed for medicinal chemists, process development scientists, pharmaceutical research teams, and academic research institutions in organic chemistry.

A medicinal chemist at a biotechnology firm needs to synthesize a novel candidate molecule for pre-clinical testing. By inputting the target structure into SYNTHIA and applying constraints on hazardous reagents, the chemist obtains multiple scalable synthesis pathways in minutes. This drastically reduces manual literature searches and accelerates laboratory execution.

• SYNTHIA is designed for medicinal chemists, process development scientists, pharmaceutical research teams, and academic research institutions in organic chemistry.
• A medicinal chemist at a biotechnology firm needs to synthesize a novel candidate molecule for pre-clinical testing.
• Advanced Retrosynthesis Engine: Combines AI algorithms with expert-encoded chemical reaction rules to automatically generate valid synthetic pathways. Accurately handles complex stereochemistry and protecting group chemistry.
• Customizable Filtering & Evaluation: Allows users to filter and rank routes by step count, cost, yield, and starting material availability. Proprietary building block databases can be incorporated.
• Interactive Pathway Visualization: Provides an intuitive interface for exploring, editing, and comparing alternative reaction trees in real time.

It is not intended for non-chemists or general office automation tasks unrelated to synthetic organic chemistry. For simple chemical reference lookup or molecular dynamics simulations, alternative specialized tools should be considered.

• Iktos — Paid · HQ: Paris, France · GDPR / EU